59 related articles for article (PubMed ID: 20530419)
1. Changes in cell-surface peptidase activity in papillary renal cell carcinoma.
Blanco L; Perez I; Sanz B; Gil J; López JI; Ugalde A; Varona A; Larrinaga G
Anticancer Res; 2010 Apr; 30(4):1137-41. PubMed ID: 20530419
[TBL] [Abstract][Full Text] [Related]
2. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.
Varona A; Blanco L; López JI; Gil J; Agirregoitia E; Irazusta J; Larrinaga G
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F780-8. PubMed ID: 16985214
[TBL] [Abstract][Full Text] [Related]
3. Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma.
Blanco L; Larrinaga G; Pérez I; López JI; Gil J; Agirregoitia E; Varona A
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F850-8. PubMed ID: 18216146
[TBL] [Abstract][Full Text] [Related]
4. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
5. Immunoelectron microscopic demonstration of the membrane proteases aminopeptidase N/CD13 and dipeptidyl peptidase IV/CD26 in normal and neoplastic renal parenchymal tissues and cells.
Stange T; Kettmann U; Holzhausen HJ
Eur J Histochem; 2000; 44(2):157-64. PubMed ID: 10968363
[TBL] [Abstract][Full Text] [Related]
6. Cystinyl aminopeptidase activity is decreased in renal cell carcinomas.
Larrinaga G; López JI; Casis L; Blanco L; Gil J; Agirregoitia E; Varona A
Regul Pept; 2007 Dec; 144(1-3):56-61. PubMed ID: 17692401
[TBL] [Abstract][Full Text] [Related]
7. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
9. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
10. Alpha-methyl CoA racemase expression in renal cell carcinomas.
Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
12. Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies.
Amo-Takyi BK; Mittermayer C; Günther K; Handt S
Br J Cancer; 2000 Apr; 82(8):1407-14. PubMed ID: 10780519
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
Schraml P; Müller D; Bednar R; Gasser T; Sauter G; Mihatsch MJ; Moch H
J Pathol; 2000 Mar; 190(4):457-61. PubMed ID: 10699995
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
15. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
16. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
[TBL] [Abstract][Full Text] [Related]
17. CD70: a new tumor specific biomarker for renal cell carcinoma.
Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
[TBL] [Abstract][Full Text] [Related]
18. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms.
Rissanen J; Korhonen M; Lehto VP; Virtanen I
J Pathol; 2003 Jun; 200(2):157-67. PubMed ID: 12754736
[TBL] [Abstract][Full Text] [Related]
19. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
